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ABSTRACT: The 12th Commonwealth Fund/Modern Healthcare Health Care Opinion Leaders 
Survey found that increased transparency in the quality and price of health care is important, 
according to a diverse group of experts. More than 80 percent of health care opinion leaders called 
for transparency on prescription drug prices and medical loss ratios (i.e., the share of premium 
dollars that private insurance companies spend on medical care). Most respondents believe 
increased transparency would reduce health care spending, primarily by stimulating providers to 
improve quality and efficiency and by allowing payers to reward such efforts. Favored policy 
strategies for improvement of health care transparency include the creation of a new public–private 
entity to standardize and implement transparency in health care; widespread adoption of health 
information technology; shared responsibility for funding across government, insurers, and providers; 
and federal leadership to create a meaningful system of public reporting on quality and price. 
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HEALTH CARE OPINION LEADERS’ VIEWS ON 
THE TRANSPARENCY OF HEALTH CARE QUALITY 
AND PRICE INFORMATION IN THE UNITED STATES 
 
Transparency in health care—including collecting and reporting public information on 
the quality and price of health care services—is essential for moving toward a higher 
performing health care system in the United States, according to the latest Health Care 
Opinion Leaders Survey. However, very limited quality information— outcomes, clinical 
processes, or patient experience of care—is routinely collected and reported. Quality and 
price transparency would stimulate improvement by giving providers feedback on their 
performance, establishing benchmark performance levels, and creating an external 
motivation to improve. It would also encourage private insurers and public programs to 
reward quality and efficiency, and help patients make informed choices about their care. 
At present, various obstacles stand in the way of improved transparency: the reliability and 
validity of current quality and price information; making information comparable across 
different populations; and how patients, providers, and consumers use the information in 
making decisions. 
 
The Health Care Opinion Leaders Survey 
The Commonwealth Fund and Modern Healthcare commissioned Harris Interactive to ask a 
diverse group of health care experts about the issue of transparency of quality and price 
information in the U.S. health care system. The 241 individuals who took part in the 
survey—the 12th in a continuing series of surveys assessing the views of experts on key 
health policy issues—represented the fields of academia and research; health care delivery; 
business, insurance, and other health industries; and government, labor, and advocacy 
groups (see Methodology, Appendix A). In the context of this study, transparency is 
defined as the public reporting of information on quality and price of health care. The 
term price refers to the effective price paid for health care services after discounts. For 
complex events such as a hospitalization or surgery, the price includes the total effective 
price for the entire event. For inpatient surgery, for instance, it would include the hospital 
bed and ancillary services; surgeon, anesthesiologist, and radiologist; and all other services 
directly related to the surgery. The survey responses closely align with the principles set 
forth by The Commonwealth Fund’s Commission on a High Performance Health System, 
which has a mission to promote greater access, quality, and efficiency across the U.S. 
health care system. The Commission recommends simultaneously embracing five key 
strategies for change: ensuring affordable coverage for all, aligning incentives and effective 
cost control, providing accountable and coordinated care, aiming higher for quality and 
efficiency, and creating accountable leadership on the national level.1
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Importance of Transparency 
A recent Commonwealth Fund survey found that 95 percent of Americans think having 
information about the quality of care provided by different doctors or hospitals is 
important, and 91 percent feel that having information about costs of care before they 
receive that care is important.2 However, the 2006 Employee Benefit Research Institute 
and the Commonwealth Fund Consumerism in Health Care Survey found that only 22 
percent to 40 percent of insured individuals—whether enrolled in a comprehensive, high-
deductible, or consumer-driven health plan—received information from their health plans 
on the cost of care provided by their doctors and hospitals. Twenty-seven percent to 47 
percent received quality information. Of those who had quality and price information, 
about half had tried using it.3 For quality and price data to be useful, American patients 
need a meaningful and practical system of health care transparency. 
 
More than three-quarters of health care opinion leaders recognize the importance 
of increased transparency in quality and price to improving health system performance in 
the U.S. (Figure 1). Eighty-four percent of business leaders think increased transparency is 
important, compared with 73 percent of academic/research leaders and two-thirds of 
government/labor/consumer leaders. 
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Figure 1. Three-Fourths of Health Care Opinion Leaders
Think Increased Transparency Is Important
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.
“How important do you think increased transparency in quality and price 
is to improving U.S. health system performance?”
Very important 
50%
Not important
2%
Important
27%
Somewhat important
21%
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The majority of opinion leaders think improved transparency would reduce health 
care spending (69%). Yet there is great variability of opinion on the impact transparency 
would have on cost: 17 percent believe it will reduce spending by greater than 5 percent 
while 31 percent think it will reduce spending by 1 percent to 5 percent (Figure 2). 
Nineteen percent of health care opinion leaders believe improved quality and price 
transparency will have no impact on spending. Business leaders surveyed are more likely to 
expect a five percent or greater reduction in health spending (29%) than are academic/ 
research leaders (13%). Twenty-one percent of academic leaders think transparency will 
have no impact on spending; only 9 percent of business leaders feel this way. 
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Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.
Reduce spending by 
1 to 5 percent
31%
Reduce spending by
less than 1 percent 
21%
Increase spending 
2%
Not sure
9% Reduce spending by
greater than 5 percent 
17%
Figure 2. More than Two Thirds of Health Care Opinion Leaders 
Think Transparency Will Reduce Total Spending 
by Five Percent or Less
“How much impact do you think quality and price transparency will have
on total U.S. health system spending?”
No impact on spending
19%
 
 
Objectives, Priorities, and Responsibility for Improved Transparency 
Health care opinion leaders were asked how much of a priority improving provider 
transparency is in three main areas of health care: clinical quality, which includes care 
processes like appropriate medication and health outcomes like mortality or infection rates; 
patients’ experience of care; and price. All groups of health care opinion leaders agree that 
transparency of clinical quality is a high priority (82%), followed by patients’ experience of 
care (53%) and price (38%) (Figure 3). 
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“How much of a priority should be attached to improving provider transparency in 
each of the following areas (high priority, a priority, or not a priority)?”
Percent responding “high priority”
Figure 3. Over Eighty Percent of Health Care Opinion Leaders 
Think Improving Transparency of Provider Clinical Quality
Is a High Priority
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.  
 
More than four of five opinion leaders think that stimulating provider performance 
improvement activities is an important objective of enhanced transparency (Figure 4). 
Other objectives include: encouraging payers to recognize or reward quality and efficiency 
(77%); helping patients make informed choices about their health care (66%); and 
informing accreditation, certification, and licensing entities in establishing and managing 
performance standards (62%). 
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Figure 4. Objectives of Enhanced Transparency on Quality
and Price According to Health Care Opinion Leaders
62
66
77
85
“Below are four potential objectives of enhanced transparency on provider quality
and price. How important is each in improving health system performance?”
Percent responding “very important/important”
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.
Stimulate provider performance 
improvement activities
Help patients make informed choices 
about their care
Inform accreditation, certification, and 
licensing entities in establishing and 
upholding performance standards
Encourage payers to recognize or reward 
quality and efficiency
 
 
Despite the two-thirds majority of health care opinion leaders who believe 
increased transparency will help patients make informed choices about their health care, 
over half of opinion leaders (53%) do not think that patients will be able to make decisions 
regarding the use of their health care dollars, given the data on price and quality available 
to them over the next two to three years (Figure 5). Only 8 percent believe it is likely 
patients will be able to make such decisions in the near future, with business leaders (16%) 
more likely than academic or research leaders (8%) to report thinking this way. 
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Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.
Not likely
53%
Not sure
3%Likely 
8%
Figure 5. Health Care Opinion Leaders Agree that Consumers 
with Health Savings Accounts Are Not Likely to Make Use of 
Price and Quality Data to Inform Health Care Decisions
“As more Americans are enrolled in high-deductible health plans and/or health savings 
accounts, the argument is made that they need access to price and quality data in order
to make best use of their own dollars. How well do you think patients will be able to make 
such decisions given the data that will be available to them over the next 2 to 3 years?”
Somewhat likely
35%
 
 
Survey respondents were also asked who they thought should be responsible for 
developing standards for quality and price and for organizing a meaningful system of 
transparency in U.S. health care. Over half of respondents support the establishment of a 
new public–private entity to coordinate standards-setting, measurement, and reporting. 
Health care delivery leaders are most likely to support professional societies setting the 
standards, measurement, and reporting of quality and price information (11% vs. less than 
5% in all other leader groups). 
 
Wide Support for Transparency of Drug Prices and Medical Loss Ratios 
Public reporting Web sites and tools for prescription drug plans are becoming increasingly 
popular. In an effort to help elderly Americans find a suitable Medicare Part D 
prescription drug plan, the Centers for Medicare and Medicaid Services created the 
Medicare Prescription Drug Plan Finder on its medicare.gov Web site. Medicare 
beneficiaries can sort through a list of available Medicare private drug plans according to 
total estimated annual cost, monthly premium, and other variables like geographic 
location, current prescription drug usage, and pharmacy preferences. Health care opinion 
leaders see such innovations as very important—84 percent of respondents support public 
reporting of drug prices charged to major purchasers like the Veterans Administration or 
Medicare Part D plans (Figure 6). Only six percent of respondents did not support 
transparency of drug prices. Business leaders are more likely than academic leaders to be 
opposed to public reporting of drug prices (13% vs. 1%). 
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Similarly, 82 percent of opinion leaders support the reporting of medical loss 
ratios; that is, the share of premium dollars that private insurance companies spend on 
actual medical care, as opposed to marketing, administration, and other expenses. Again, 
business leaders, including representatives from the insurance industry, were less likely 
to support public reporting of medical loss ratios (74%) than were health care delivery 
leaders (90%). 
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Figure 6. Health Care Opinion Leaders Call for Public Reporting 
of Medical Loss Ratios and Drug Prices by Health Plans
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.
Strongly
support
54%
Not sure
1%
Somewhat 
support
9%
Do not 
support
5%
“Do you support public reporting 
of health plan medical loss ratios 
(percentage of premium dollars
spent on medical care)?”
Support
28%
“Do you support public reporting of drug 
prices charged to major purchasers 
(e.g., the Veterans Administrations, 
Medicaid, Medicare Part D plans)?”
Not sure
2%
Somewhat 
support
8%
Do not 
support
6%
Support
23%
Strongly 
support 
61%
 
 
Policy Action to Create Transparency 
There are significant, multiple barriers to improved transparency in the U.S. health system. 
Even when financial and quality data are collected, there are challenges in making the 
information comparable across providers and plans and comprehensible to the various 
audiences, including patients and consumers. Surveyed experts named a number of key 
policy strategies to improve health care quality and price transparency, including: 
• sharing the cost of data collection for performance measurement across providers, 
insurers, and the government (75%) (Figure 7); 
• widespread adoption of health information technology (88%) (Figure 8); 
• establishing a new public–private national entity to set standards for measurement 
and reporting and to be accountable for health system transparency (56%); and 
• differential payment to providers based on publicly reported quality and price 
data (54%). 
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Figure 7. Three-Fourths of Health Care Opinion Leaders Support 
Cost-Sharing for Data Collection of Performance Measurement
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.
“Data collection for performance measurement can be costly. 
Who should bear the burden of these costs?”
Costs should be shared 
between providers, 
insurers, and the 
government 
75%
Insurers
11%
Government
7%
Providers
5%
Not sure
2%
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Figure 8. Health Care Opinion Leaders Call for
Widespread Adoption of Health Information Technology
to Achieve System of Transparency
“How important is widespread adoption of health information technology
to achieving a meaningful system of transparency?”
Very important
68%
Important
20%
Somewhat important
10%
Not important
2%
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.  
 
All opinion leader sectors were in agreement about the importance of health 
information technology and the establishment of a new public–private entity to coordinate 
transparency information. However, business leaders were most likely to support 
differential payment based on publicly reported data (71%) than were health care delivery 
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leaders (50%). Further, respondents from the health care delivery sector were most likely 
to say insurers should bear the cost of data collection for performance measurement, while 
business and insurance leaders were more likely to support sharing the costs among 
providers, insurers, and government (77%). 
 
A Wall Street Journal/Harris Interactive poll recently found that providing health 
coverage to the uninsured is the top-rated health policy issue, with slowing inflation in 
health care costs a close second.4 Recognizing the public attention to this issue, most of 
the presidential candidates have put forward health reform proposals. Seventy percent of 
health care opinion leaders surveyed believe it is important for presidential candidates to 
include an accessible and meaningful system of public reporting on quality and price in 
their proposals (Figure 9). Business leaders were most likely (74%) to think transparency is 
an important component of such proposals. 
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Figure 9. Seventy Percent of Opinion Leaders Agree
that Presidential Candidates Should Include Public Reporting
in Their Health Care Proposals
“As part of their health reform proposals, how important is it for presidential candidates to 
include an accessible and meaningful system of public reporting on quality and price?”
Not important
11%
Very important
34%
Important
36%
Somewhat important
17%
Not sure
2%
Source: Commonwealth Fund Health Care Opinion Leaders Survey, November 2007.  
 
Moving Toward a High Performance Health System 
With ever-increasing numbers of uninsured Americans, rapidly rising health care costs, 
and concerns about the quality of care, more and more Americans see a health system in 
crisis. The Commonwealth Fund Commission on a High Performance Health System has 
defined a high performance health system for the United States as one that helps everyone, 
to the extent possible, lead longer, healthier, and more productive lives. To accomplish 
that, the health care system must achieve four core goals: access to care for all Americans; 
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safe, high quality care; efficient, high value care; and continuous innovation and 
improvement. Along these lines, the Commission has stated that in addition to embracing 
coverage and access for all, it will be critical for the next president to: 
• achieve sufficient cost containment to alter the trajectory of health care costs; 
• organize the health system to make it easy for patients to obtain the 
comprehensive, coordinated care they need and for providers to practice the best 
of modern medicine;  
• commit the money and leadership required to implement an electronic 
information system within a reasonable period, aiming for five years; and  
• establish national goals and what it takes to reach them.5 
 
In particular, the Commission seeks opportunities to change the delivery and 
financing of health care to improve system performance and identifies public and private 
policies and practices that would lead to those improvements. Specifically, the 
Commission has called for a significant investment in public reporting for improvement 
and accountability. It believes that public information should include health outcomes, 
technical quality indicators, patient experiences, and total cost of care for major conditions 
or services by the relevant accountable entity, including hospitals, physicians, practices, 
integrated delivery systems, care networks, laboratories, imaging centers, and other health 
care organizations and providers.6 The policy strategy of enhanced transparency of quality 
and price supported by health care opinion leaders directly aligns with the Commission’s 
goals and policy strategies. These include widespread adoption of health information 
technology, establishment of a new public–private national entity to set standards for 
measurement and reporting and to be accountable for health system transparency, and 
differential payment to providers based on publicly reported quality and price data. 
 
One step toward enhanced transparency in health care is making clear, 
understandable information available to the public on health outcomes; quality, prices, and 
total costs of health care services and pharmaceuticals; and insurance plan premiums and 
medical care outlays. Until we have accurate information on comparative performance 
that is appropriately adjusted for the complexity of patients’ conditions, it will be difficult 
to identify areas for achievable savings and improved performance. Quality and price 
transparency is a good start, but is unlikely to have a major impact in the absence of better 
information on quality and total costs for the treatment of various acute and chronic 
conditions.7 Health care opinion leaders view the upcoming election and the current 
climate in Washington as an historic opportunity for federal leadership to work to ensure 
all Americans access to a high performing health care system. 
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METHODOLOGY 
 
The Commonwealth Fund/Modern Healthcare Health Care Opinion Leaders Survey 
was conducted online by Harris Interactive between Oct. 1, 2007, and Oct. 28, 2007. 
The survey was administered via e-mail to a panel of 1,294 opinion leaders in health 
policy and innovators in health care delivery and finance. The final sample included 
241 respondents from various industries. Typically, samples of this size are associated 
with a sampling error of +/– 6.3 percent. However, that does not take other sources 
of error into account. This online survey is not based on a probability sample and 
therefore no theoretical sampling error can be calculated. The sample was developed 
by The Commonwealth Fund, Modern Healthcare, and Harris Interactive. Data 
from this survey were not weighted. 
 
Tables with complete survey results, broken down by audience affiliation, are 
available from The Commonwealth Fund, upon request.  
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